Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005845
Status:
COMPLETED
Last Update Posted:
2013-12-16
First Post:
2000-06-02
Brief Title:
Tipifarnib in Treating Patients With Myelodysplastic Syndromes
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Cytopenia With Multilineage Dysplasia |
| Chronic Myelomonocytic Leukemia |
| de Novo Myelodysplastic Syndromes |
| Previously Treated Myelodysplastic Syndromes |
| Refractory Anemia |
| Refractory Anemia With Excess Blasts |
| Refractory Anemia With Excess Blasts in Transformation |
| Refractory Anemia With Ringed Sideroblasts |
Keywords: